tiprankstipranks
Trending News
More News >
Guided Therapeutics Inc (GTHP)
OTHER OTC:GTHP
US Market
Advertisement

Guided Therapeutics (GTHP) Ratios

Compare
24 Followers

Guided Therapeutics Ratios

GTHP's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, GTHP's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.14 0.29 0.62 0.29 0.10
Quick Ratio
0.03 0.16 0.50 0.19 0.03
Cash Ratio
0.02 0.12 0.48 0.11 0.02
Solvency Ratio
-26.88 -0.62 -0.78 -0.50 -0.11
Operating Cash Flow Ratio
-0.23 -0.36 -0.30 -0.28 -0.21
Short-Term Operating Cash Flow Coverage
-0.70 -1.34 -1.66 -1.40 -0.56
Net Current Asset Value
$ 715.00K$ -4.08M$ -3.25M$ -5.85M$ -11.31M
Leverage Ratios
Debt-to-Assets Ratio
2.08 1.23 0.67 1.42 3.26
Debt-to-Equity Ratio
2.31 -0.54 -0.78 -0.53 -0.41
Debt-to-Capital Ratio
0.70 -1.18 -3.65 -1.14 -0.68
Long-Term Debt-to-Capital Ratio
0.10 -0.16 -0.64 -0.34 -0.06
Financial Leverage Ratio
1.11 -0.44 -1.17 -0.37 -0.12
Debt Service Coverage Ratio
-1.06 -1.98 -2.94 -1.12 -0.06
Interest Coverage Ratio
-12.72 -12.44 -5.73 -2.05 -1.00
Debt to Market Cap
0.10 0.23 0.21 0.32 1.04
Interest Debt Per Share
0.03 0.05 0.09 0.30 0.51
Net Debt to EBITDA
-0.93 -0.47 0.01 -2.45 5.44
Profitability Margins
Gross Profit Margin
-525.00%36.73%-523.08%24.69%59.80%
EBIT Margin
42450.00%-3276.53%-28915.38%-1135.80%761.76%
EBITDA Margin
51000.00%-3189.80%-28361.54%-1134.57%761.76%
Operating Profit Margin
54075.00%-3527.55%-25638.46%-2916.05%-1031.37%
Pretax Profit Margin
61050.00%-3560.20%-33392.31%-2555.56%-273.53%
Net Profit Margin
66300.00%-3560.20%-38246.15%-4601.23%-1308.82%
Continuous Operations Profit Margin
54725.00%-3560.20%-33392.31%-2555.56%-273.53%
Net Income Per EBT
108.60%100.00%114.54%180.05%478.49%
EBT Per EBIT
112.90%100.93%130.24%87.64%26.52%
Return on Assets (ROA)
-274.25%-209.05%-147.71%-182.70%-98.89%
Return on Equity (ROE)
77.98%91.67%172.46%68.45%12.30%
Return on Capital Employed (ROCE)
43.86%110.10%221.76%64.64%13.82%
Return on Invested Capital (ROIC)
76.71%197.77%712.22%173.79%119.23%
Return on Tangible Assets
-274.25%-209.05%-147.71%-182.70%-98.89%
Earnings Yield
-15.53%-44.45%-50.99%-48.04%-35.17%
Efficiency Ratios
Receivables Turnover
-2.00 14.00 2.17 1.76 4.25
Payables Turnover
-0.01 0.03 0.04 0.02 0.02
Inventory Turnover
-0.04 0.10 0.15 0.11 0.07
Fixed Asset Turnover
-0.03 0.38 0.04 0.21 0.22
Asset Turnover
>-0.01 0.06 <0.01 0.04 0.08
Working Capital Turnover Ratio
<0.01 -0.04 >-0.01 -0.01 -0.01
Cash Conversion Cycle
21.99K -8.16K -7.39K -11.03K -17.10K
Days of Sales Outstanding
-182.50 26.07 168.46 207.28 85.88
Days of Inventory Outstanding
-9.24K 3.72K 2.47K 3.42K 5.39K
Days of Payables Outstanding
-31.42K 11.91K 10.03K 14.65K 22.57K
Operating Cycle
-9.42K 3.75K 2.64K 3.62K 5.47K
Cash Flow Ratios
Operating Cash Flow Per Share
-0.02 -0.03 -0.05 -0.12 -0.17
Free Cash Flow Per Share
-0.02 -0.03 -0.05 -0.12 -0.17
CapEx Per Share
0.00 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.02 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
-37.50 0.00 -47.68 -113.71 -1.88K
Capital Expenditure Coverage Ratio
0.00 0.00 -47.68 -113.71 -1.88K
Operating Cash Flow Coverage Ratio
-0.67 -0.85 -0.65 -0.55 -0.43
Operating Cash Flow to Sales Ratio
337.50 -17.82 -113.69 -19.65 -18.38
Free Cash Flow Yield
-6.84%-22.25%-15.47%-20.70%-49.42%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-6.44 -2.25 -1.96 -2.08 -2.84
Price-to-Sales (P/S) Ratio
-4.93K 80.09 750.12 95.79 37.21
Price-to-Book (P/B) Ratio
19.60 -2.06 -3.38 -1.42 -0.35
Price-to-Free Cash Flow (P/FCF) Ratio
-14.61 -4.50 -6.46 -4.83 -2.02
Price-to-Operating Cash Flow Ratio
-12.65 -4.50 -6.60 -4.87 -2.02
Price-to-Earnings Growth (PEG) Ratio
1.08 0.04 0.04 -0.02 0.03
Price-to-Fair Value
19.60 -2.06 -3.38 -1.42 -0.35
Enterprise Value Multiple
-10.60 -2.98 -2.63 -10.90 10.32
Enterprise Value
21.62M 9.32M 9.70M 10.01M 8.02M
EV to EBITDA
-10.60 -2.98 -2.63 -10.90 10.32
EV to Sales
-5.41K 95.06 746.27 123.64 78.62
EV to Free Cash Flow
-16.02 -5.34 -6.43 -6.24 -4.27
EV to Operating Cash Flow
-16.02 -5.34 -6.56 -6.29 -4.28
Tangible Book Value Per Share
0.01 -0.07 -0.09 -0.41 -1.01
Shareholders’ Equity Per Share
0.01 -0.07 -0.09 -0.41 -1.01
Tax and Other Ratios
Effective Tax Rate
-0.07 0.00 -0.15 -0.80 -3.78
Revenue Per Share
>-0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
-0.04 -0.07 -0.15 -0.28 -0.12
Tax Burden
1.09 1.00 1.15 1.80 4.78
Interest Burden
1.44 1.09 1.15 2.25 -0.36
Research & Development to Revenue
-136.50 2.33 5.92 0.85 1.40
SG&A to Revenue
-332.00 30.58 231.31 26.81 8.95
Stock-Based Compensation to Revenue
-27.25 18.43 106.23 2.81 3.04
Income Quality
0.55 0.50 0.34 0.77 6.72
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis